Covered recipient · General Payments record
DEREK VANAMERONGEN
Allopathic & Osteopathic Physicians Obstetrics & Gynecology Gynecology
General Payments · PY2018–2024
$361,079.78
- Reported across 242 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $56,604.62 | 15 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,550.00 | 1 |
| Travel and Lodging | $4,491.61 | 9 |
| Honoraria | $3,200.00 | 2 |
| Food and Beverage | $769.52 | 4 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Eli Lilly and Company | $25,850.00 | 6 |
| Amgen Inc. | $10,100.00 | 11 |
| Medtronic, Inc. | $9,380.00 | 1 |
| PFIZER INC. | $6,835.72 | 5 |
| Novo Nordisk AS | $5,400.00 | 2 |
| Lilly USA, LLC | $4,400.00 | 1 |
| CHIESI USA, INC. | $3,000.00 | 1 |
| Johnson & Johnson Health Care Systems Inc. | $1,875.00 | 1 |
| CLINIGEN, INC. | $1,399.62 | 2 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,375.41 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (31)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $173.75 | 05/03/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1117707504 | CMS |
| Amgen Inc. | $276.74 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117707506 | CMS |
| Amgen Inc. | $80.91 | 05/03/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1117707508 | CMS |
| Amgen Inc. | $173.75 | 05/03/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1117707516 | CMS |
| Amgen Inc. | $149.38 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117707518 | CMS |
| Amgen Inc. | $173.75 | 05/03/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1117707520 | CMS |
| Amgen Inc. | $294.98 | 05/03/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1117707522 | CMS |
| Amgen Inc. | $276.74 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117707524 | CMS |
| Amgen Inc. | $1,500.00 | 05/21/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1117707510 | CMS |
| Amgen Inc. | $3,500.00 | 05/21/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1117707514 | CMS |
| Amgen Inc. | $3,500.00 | 05/22/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1117707512 | CMS |
| Chiesi USA, Inc. | $3,000.00 | 01/04/2024 | Honoraria | Undisputed | 01/23/2026 | 1151823584 | CMS |
| Clinigen, Inc. | $1,199.62 | 07/12/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1071129708 | CMS |
| Clinigen, Inc. | $200.00 | 11/15/2024 | Honoraria | Undisputed | 01/23/2026 | 1071129712 | CMS |
| Eli Lilly and Company | $5,500.00 | 02/08/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1136150213 | CMS |
| Eli Lilly and Company | $4,400.00 | 03/25/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1136155272 | CMS |
| Eli Lilly and Company | $4,400.00 | 05/22/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1136141955 | CMS |
| Eli Lilly and Company | $2,750.00 | 07/05/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1136143509 | CMS |
| Eli Lilly and Company | $4,400.00 | 09/18/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1136150215 | CMS |
| Eli Lilly and Company | $4,400.00 | 12/09/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1136141953 | CMS |
| Johnson & Johnson Health Care Systems Inc. | $1,875.00 | 02/29/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1077573080 | CMS |
| Lilly USA, LLC | $4,400.00 | 11/22/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1136150217 | CMS |
| Medtronic, Inc. | $9,380.00 | 12/10/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1112050839 | CMS |
| Novo Nordisk AS | $3,600.00 | 06/18/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1096552025 | CMS |
| Novo Nordisk AS | $1,800.00 | 06/18/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1096553441 | CMS |
| PFIZER INC. | $646.30 | 11/13/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1131588071 | CMS |
| PFIZER INC. | $1,042.55 | 11/13/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1131588075 | CMS |
| PFIZER INC. | $530.21 | 11/13/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1131588079 | CMS |
| PFIZER INC. | $66.66 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131588083 | CMS |
| PFIZER INC. | $4,550.00 | 12/09/2024 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Undisputed | 01/23/2026 | 1131238495 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,375.41 | 04/29/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1153707695 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.